Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Ischemic Heart Failure
NCT00759811Phase 3Completed
- Sponsor
- Instituto de Cardiologia do Rio Grande do Sul
- Start
- Dec 2007
- Primary completion
- Nov 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Ischemic Heart Failure (IHF) comparing Methotrexate with Placebo (2 arms). Primary endpoint: Change in Physical Capacity Measured Using the 6-minute Walk Test Distance at 12 weeks. Started Dec 2007; status: completed.
02
Drugs
methotrexate
03
Conditions
Ischemic Heart Failure (IHF)
Beyond the preview
Go deeper on NCT00759811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759811.